Download 1 Top Pediatric Medications Common Pediatric

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Discovery and development of cephalosporins wikipedia , lookup

Specialty drugs in the United States wikipedia , lookup

Drug discovery wikipedia , lookup

Bad Pharma wikipedia , lookup

Psychedelic therapy wikipedia , lookup

Neuropharmacology wikipedia , lookup

Orphan drug wikipedia , lookup

Polysubstance dependence wikipedia , lookup

Stimulant wikipedia , lookup

Adherence (medicine) wikipedia , lookup

Pharmaceutical industry wikipedia , lookup

Neuropsychopharmacology wikipedia , lookup

Drug interaction wikipedia , lookup

Prescription drug prices in the United States wikipedia , lookup

Prescription costs wikipedia , lookup

Pharmacognosy wikipedia , lookup

Medication wikipedia , lookup

Pharmacogenomics wikipedia , lookup

Psychopharmacology wikipedia , lookup

Transcript
Common Pediatric Conditions
Top Pediatric Medications
How to Use Them Safely
Elizabeth VandeWaa, PhD
Lecturer/Consultant
Barkley and Associates
Professor
University of South Alabama
Asthma
y Attention-deficit hyperactivity disorder
(ADHD)
y Infections
y Pain/fever
y Allergies
y Gastrointestinal (GI) complaints
y
Factors Unique to Pediatric
Pharmacology
Conditions of Interest
Hyperlipidemia
y Psychosis
y Autism
y Depression
y
Factors Unique to Pediatric
Pharmacology
y
y
Children one to 12 years of age.
Metabolism:
Ń Is generally faster than normal adult levels
until age 2, then slowly declines until puberty,
and finally drops to normal adult levels.
Ń This may mean increased dosage or dosing
frequency for drugs eliminated by hepatic
metabolism.
Babies
y Underdeveloped metabolic and
excretory processes:
y
Ń Conjugation reactions are not developed
until one year of age. Hence, many drugs
cannot be used in neonates, newborns,
and infants up to one year of age.
Ń Excretory processes are not at adult
levels until 1 year of age.
Drug Dosing in Children
y
Doses are often extrapolated from adult
doses:
Ń Based on body surface area.
Ń Approximation.
y
Future dosing should be done based on
clinical outcome to maximize therapeutic
benefit and minimize adverse effects.
1
Top Twenty Drugs Prescribed in
Pediatric Medicine
Top Twenty Drugs Prescribed in
Pediatric Medicine
Hydroxyzine (Atarax)
Ciprofloxacin/dexamethasone
(Ciprodex Otic)
y Amoxicillin/clavulanate (Augmentin)
y Budesonide (Pulmicort)
y Mupirocin (Bactroban Topical)
y Prednisolone (Orapred Oral Liquid)
y TMP/sulfa (Bactrim Pediatric)
y Triamcinolone (Kenalog)
Amoxicillin
y Ceterizine (Zyrtec)
y Albuterol for inhalation
y Azithromycin (Zithromax)
y Children’s Motrin
y Cefdinir (Omnicef)
y Mometasone (Nasonex)
y Montelukast (Singulair)
y
y
Top Twenty Drugs Prescribed in
Pediatric Medicine
y
Drugs by Classification
Infants’ Tylenol
y Nystatin Topical
y Loratadine (Claritin)
y Polyethylene glycol (MiraLax)
y
Drugs by Classification
Acute Otitis Media (AOM)
y
y
Asthma/Allergy
Ń
Ń
Ń
Ń
Ń
Ń
Ń
Ń
Zyrtec
Albuterol Inhalation
Nasonex
Singulair
Pulmicort
Claritin
Orapred
Kenalog
Infection
Ń
Ń
Ń
Ń
Ń
Ń
Ń
Ń
Amoxicillin
Zithromax
Omnicef
Ciprodex
Augmentin
Bactroban
Bactrim
Nystatin
AOM is one of the most common
childhood infections.
y 30 to 35 million cases per year.
y Initial peak age of incidence occurs
between six to 12 months of age.
y Second peak age of incidence occurs
between four and five years of age.
y Accounts for 3% of all visits.
y Is the #1 reason for a prescription.
y
2
AOM with Effusion
AOM: To Treat, or Not to Treat?
y
Three signs and symptoms must be
present:
Ń Acute onset of signs and symptoms.
x Fever, pain.
Ń Middle-ear effusion
x Often difficult to confirm.
Ń Middle-ear inflammation
x Erythema and/or otalgia.
AOM: To Treat, or Not to Treat?
y
y
Pain medications are always indicated, as
are relief measures.
More than 80% of AOM cases resolve
spontaneously within a week.
Ń Treating with antibiotics means unnecessary
costs, risk of SE, and increases the chance for
emergence of resistance.
y
AOM: When to Treat
y
Less than 6 months old:
y
Six months to two years of age:
Ń Treat with antibiotics.
Ń Antibiotics if diagnosis is certain or
disease is severe; otherwise, observe
patient.
y
Ń Antibiotics if illness is severe; observation
if not severe even with a certain diagnosis.
If diagnosis is uncertain, observe patient.
Observation for 48 to 72 hours is most
often warranted.
Ń Delaying treatment does not increase risk of
mastoiditis.
AOM Drugs of Choice
y
Amoxicillin 40 to 45 mg/kg twice a day.
Ń Cefdinir (Omnicef): For non-type 1 allergy, 14
mg/kg/day in one or two doses.
Ń Azithromycin: For type 1 allergy, 10 mg/kg day
one and 5 mg/kg on days two through five.
y
For persistent symptoms after 48 to 72
hours:
Ń Augmentin ES-600 twice a day.
Ń Ceftriaxone: Non-type 1 allergy, 50 mg/kg.
Ń Clindamycin: Type 1 allergy, 30 to 40 mg/kg/day
in three divided doses.
Two years and older:
Bugs That Cause AOM and
Resistance
y
y
y
y
Haemophilus influenzae and Moraxella
catarrhalis are most likely to be resistant
to beta-lactam antibiotics.
Streptococcus pneumoniae is resistant to
erythromycin, beta-lactams, and TMPSulfa.
Vaccination against influenza and
treatment with oseltamivir are
associated with a decreased incidence of
AOM during flu season.
Vaccination against S. pneumoniae is
associated with a decreased incidence of
AOM.
3
Resistance and Recurrence
y
Resistance is best treated with highdose amoxicillin/clavulanic acid
(Augmentin ES-600).
y
Recurrence is defined as three or
more episodes in six months, or four
or more in 12 months.
Otitis Externa - Swimmer’s Ear
Ń Alternatively, parenteral ceftriaxone.
Ń Prophylaxis has not been shown to be
effective.
Ń Use only during cold and flu season.
Ń Select amoxicillin.
Otitis Externa
TREATMENT OF
ASTHMA
Treated easily, and inexpensively, with
either a 2% solution of acetic acid, or a
solution of alcohol plus acetic acid.
y If either of the above do not work,
Ciprodex may be used.
y
Ń Consider cost.
Ń Consider promotion of resistance.
Treatment of Asthma
y
Epidemiology of asthma
Ń Process and triggers
y
Treatment of Asthma
y
Epidemiology of asthma:
Ń Process, triggers.
Drugs for asthma
Ń Delivery methods
Ń Recommendations
Monitoring drug efficacy
Other strategies for the patient with
asthma.
y Summary
y
y
4